Article Text
PDFMailbox
PostScript
Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration
Statistics from Altmetric.com
Footnotes
Funding: Research supported by an unrestricted grant from the Research to Prevent Blindness Organization, New York, NY.
Competing interests: None.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
2008 BMJ Publishing Group Ltd